|
||
|
The anti-proliferative effects of different concentrations of PIP in combination with 146.510 µM RES against the EMT-6/P cell line. |
|
||||||||
| Part of: AlHur MJ, Barakova N, Talib WH (2024) Combination of resveratrol and piperine to target doxorubicin resistance in breast cancer: An in vitro and in vivo study. Pharmacia 71: 1-10. https://doi.org/10.3897/pharmacia.71.e122171 |